Daan Gene (SHE:002030) received approval from the Chinese drug administration for the registration of its genetic deafness detection kit, according to a Shenzhen Stock Exchange filing on Wednesday.
The kit is used to detect deafness through the blood samples of newborns.
The certificate is valid until Dec. 16, 2029, the Chinese pathogen detection reagent kit manufacturer said.